AQST

Aquestive Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

15.8%

Short % Float

8.9d to cover · Moderate squeeze

61.3%

Inst % Float

10 holders · 2026-06-30

Bratton Capital Ma

Top Holder

7.8% of float

114.5M sh

Public Float

32/100

Dilution Score

Medium

33 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

32/100

MEDIUM

Inst: 61.31% · Top: Bratton Capital Management, LP

Biotech Analytics

CNS

8.85

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk32

Clinical Trials0

Short Interest50